PATENT DUCTUS ARTERIOSUS
Clinical trials for PATENT DUCTUS ARTERIOSUS explained in plain language.
Never miss a new study
Get alerted when new PATENT DUCTUS ARTERIOSUS trials appear
Sign up with your email to follow new studies for PATENT DUCTUS ARTERIOSUS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New study weighs risks of treating vs. watching heart defect in preemies
Disease control OngoingThis study looks at whether actively treating a heart condition called patent ductus arteriosus (PDA) in premature babies is better than simply monitoring it. About 482 infants born between 22 and 28 weeks of pregnancy will be followed to see which approach reduces the risk of de…
Matched conditions: PATENT DUCTUS ARTERIOSUS
Phase: PHASE3 • Sponsor: NICHD Neonatal Research Network • Aim: Disease control
Last updated Jun 27, 2026 12:32 UTC
-
Heart device for preemies under scrutiny in new safety study
Disease control OngoingThis study monitors 70 infants who receive the Amplatzer Piccolo Occluder to close a hole in the heart called patent ductus arteriosus (PDA). The device is placed through a blood vessel, avoiding open-heart surgery. Researchers track complications and how well the hole closes ove…
Matched conditions: PATENT DUCTUS ARTERIOSUS
Sponsor: Abbott Medical Devices • Aim: Disease control
Last updated Jun 27, 2026 07:53 UTC
-
Study aims to predict which preterm babies need treatment for a heart vessel that often closes on its own
Knowledge-focused OngoingThis study follows 526 preterm infants born before 30 weeks who have a condition called patent ductus arteriosus (PDA), where a fetal blood vessel stays open too long. Researchers collect heart ultrasound, blood, and urine tests over the first month to predict which babies will c…
Matched conditions: PATENT DUCTUS ARTERIOSUS
Sponsor: Nationwide Children's Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:00 UTC